⌘K

Home/Filings/4/0001878894-21-000011

4//SEC Filing

Gutry Phil 4

Accession 0001878894-21-000011

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:45 PM ET

Size

5.2 KB

Accession

0001878894-21-000011

Insider Transaction Report

Form 4

Period: 2021-09-30

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2021-09-30+4,718→ 4,718 total
Exercise: $2.18From: 2021-09-30Exp: 2031-09-30→ Common Stock (4,718 underlying)

Footnotes (1)

[F1]100% of this stock option will immediately vest on the date that it is granted.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001653224

Filing Metadata

Form type: 4
Filed: Oct 3, 8:00 PM ET
Accepted: Oct 4, 4:45 PM ET
Size: 5.2 KB

View on SEC.gov